These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27407233)

  • 1. Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy.
    Kuryliszyn-Moskal A; Kita J; Hryniewicz A
    Reumatologia; 2015; 53(2):87-93. PubMed ID: 27407233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of nailfold videocapillaroscopy in Raynaud's phenomenon monitoring and early diagnosis of systemic sclerosis].
    Cutolo M; Pizzorni C; Meroni M; Zampogna G; Ferrone C; Alessandri E; Sulli A
    Reumatismo; 2010; 62(4):237-47. PubMed ID: 21253616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus-based evaluation of dermatoscopy versus nailfold videocapillaroscopy in Raynaud's phenomenon linking USA and Europe: a European League against Rheumatism study group on microcirculation in rheumatic diseases project.
    Radic M; Snow M; Frech TM; Saketkoo LA; Cutolo M; Smith V
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):132-136. PubMed ID: 32865167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylphenidate and secondary Raynaud's phenomenon].
    Iglesias Otero M; Portela Romero M; Bugarín González R; Ventura Victoria MA
    Semergen; 2013 Sep; 39(6):330-4. PubMed ID: 24034762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shadow zone of capillaroscopy in the classification of the Raynaud's phenomenon.
    Sirufo MM; Magnanimi LM; Ginaldi L; De Martinis M
    Curr Med Res Opin; 2022 Apr; 38(4):637-639. PubMed ID: 35227144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey).
    Ingegnoli F; Ughi N; Dinsdale G; Orenti A; Boracchi P; Allanore Y; Foeldvari I; Sulli A; Cutolo M; Smith V; Herrick AL;
    Rheumatol Int; 2017 Nov; 37(11):1879-1890. PubMed ID: 28894946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon.
    Ruaro B; Smith V; Sulli A; Pizzorni C; Tardito S; Patané M; Paolino S; Cutolo M
    Front Pharmacol; 2019; 10():360. PubMed ID: 31073287
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon.
    Herrick AL; Murray A
    Autoimmun Rev; 2018 May; 17(5):465-472. PubMed ID: 29526628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Raynaud's phenomenon, very early and early scleroderma tips for a timely diagnosis.
    Sirufo MM; Magnanimi LM; Ginaldi L; De Martinis M
    Eur J Intern Med; 2022 Apr; 98():111-112. PubMed ID: 35120748
    [No Abstract]   [Full Text] [Related]  

  • 11. Nailfold Videocapillaroscopy in Connective Tissue Diseases with Raynaud's Phenomenon in an Indian Population.
    Sundaray S; Mishra S; Dash SC; Sundaray NK
    Rambam Maimonides Med J; 2022 Jan; 13(1):. PubMed ID: 35089122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microangiopathy in Naifold Videocapillaroscopy and Its Relations to sE- Selectin, Endothelin-1, and hsCRP as Putative Endothelium Dysfunction Markers among Adolescents with Raynaud's Phenomenon.
    Gorski S; Bartnicka M; Citko A; Żelazowska-Rutkowska B; Jablonski K; Gorska A
    J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31027378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The usefulness of capillaroscopy for the evaluation of pulsed magnetic field therapy in patients with primary and secondary Raynaud's phenomenon].
    Kuryliszyn-Moskal A; Kita J; Dakowicz A; Klimiuk PA
    Ann Acad Med Stetin; 2011; 57(3):17-22; discussion 22. PubMed ID: 23383543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon and nailfold capillaroscopic findings in anorexia nervosa.
    De Martinis M; Sirufo MM; Ginaldi L
    Curr Med Res Opin; 2018 Mar; 34(3):547-550. PubMed ID: 29292666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillaroscopy in the screening and diagnosis of Raynaud's phenomenon.
    Mannarino E; Pasqualini L; Fedeli F; Scricciolo V; Innocente S
    Angiology; 1994 Jan; 45(1):37-42. PubMed ID: 8285382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective capillaroscopy-based study on transition from primary to secondary Raynaud's phenomenon: preliminary results.
    Bernero E; Sulli A; Ferrari G; Ravera F; Pizzorni C; Ruaro B; Zampogna G; Alessandri E; Cutolo M
    Reumatismo; 2013 Oct; 65(4):186-91. PubMed ID: 24192563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raynaud's phenomenon: from molecular pathogenesis to therapy.
    Prete M; Fatone MC; Favoino E; Perosa F
    Autoimmun Rev; 2014 Jun; 13(6):655-67. PubMed ID: 24418302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomenon].
    Tolosa Vilella C; Simeón Aznar CP; Gabarró Julià L
    Med Clin (Barc); 2009 May; 132(18):712-8. PubMed ID: 19268319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.